Dysart K - Search Results

1

Research in high flow therapy: mechanisms of action.

Dysart K, Miller TL, Wolfson MR, Shaffer TH. Dysart K, et al. Respir Med. 2009 Oct;103(10):1400-5. doi: 10.1016/j.rmed.2009.04.007. Epub 2009 May 21. Respir Med. 2009. PMID: 19467849 Review.

2

Sequela of preterm versus term infants born to mothers on a methadone maintenance program: differential course of neonatal abstinence syndrome.

Dysart K, Hsieh HC, Kaltenbach K, Greenspan JS. Dysart K, et al. J Perinat Med. 2007;35(4):344-6. doi: 10.1515/JPM.2007.063. J Perinat Med. 2007. PMID: 17511598

3

Safety and Long Term Outcomes with High Flow Nasal Cannula Therapy in Neonatology: A Large Retrospective Cohort Study.

McQueen M, Rojas J, Sun SC, Tero R, Ives K, Bednarek F, Owens L, Dysart K, Dungan G, Shaffer TH, Miller TL. McQueen M, et al. Among authors: dysart k. J Pulm Respir Med. 2014 Dec;4(6):216. doi: 10.4172/2161-105X.1000216. J Pulm Respir Med. 2014. PMID: 26167395 Free PMC article.

4

High Flow Nasal Cannula Use Is Associated with Increased Morbidity and Length of Hospitalization in Extremely Low Birth Weight Infants.

Taha DK, Kornhauser M, Greenspan JS, Dysart KC, Aghai ZH. Taha DK, et al. Among authors: dysart kc. J Pediatr. 2016 Jun;173:50-55.e1. doi: 10.1016/j.jpeds.2016.02.051. Epub 2016 Mar 19. J Pediatr. 2016. PMID: 27004673 Free PMC article.

5

Sequential alterations of tracheal mechanical properties in the neonatal lamb: effect of mechanical ventilation.

Miller TL, Zhu Y, Altman AR, Dysart K, Shaffer TH. Miller TL, et al. Among authors: dysart k. Pediatr Pulmonol. 2007 Feb;42(2):141-9. doi: 10.1002/ppul.20549. Pediatr Pulmonol. 2007. PMID: 17123318

6

High-flow nasal cannula: impact on oxygenation and ventilation in an acute lung injury model.

Frizzola M, Miller TL, Rodriguez ME, Zhu Y, Rojas J, Hesek A, Stump A, Shaffer TH, Dysart K. Frizzola M, et al. Among authors: dysart k. Pediatr Pulmonol. 2011 Jan;46(1):67-74. doi: 10.1002/ppul.21326. Epub 2010 Nov 23. Pediatr Pulmonol. 2011. PMID: 21171186 Free PMC article.

7

Early caffeine therapy for prevention of bronchopulmonary dysplasia in preterm infants.

Taha D, Kirkby S, Nawab U, Dysart KC, Genen L, Greenspan JS, Aghai ZH. Taha D, et al. J Matern Fetal Neonatal Med. 2014 Nov;27(16):1698-702. doi: 10.3109/14767058.2014.885941. Epub 2014 Feb 17. J Matern Fetal Neonatal Med. 2014. PMID: 24479608

8

Physiologic Basis for Nasal Continuous Positive Airway Pressure, Heated and Humidified High-Flow Nasal Cannula, and Nasal Ventilation.

Dysart KC. Dysart KC. Clin Perinatol. 2016 Dec;43(4):621-631. doi: 10.1016/j.clp.2016.07.001. Clin Perinatol. 2016. PMID: 27837748 Review.

9

Changing use of surfactant over 6 years and its relationship to chronic lung disease.

Chong E, Greenspan J, Kirkby S, Culhane J, Dysart K. Chong E, et al. Among authors: dysart k. Pediatrics. 2008 Oct;122(4):e917-21. doi: 10.1542/peds.2007-3193. Epub 2008 Sep 29. Pediatrics. 2008. PMID: 18824498

10

The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach.

Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, Kirpalani H, Laughon MM, Poindexter BB, Duncan AF, Yoder BA, Eichenwald EC, DeMauro SB. Jensen EA, et al. Among authors: dysart k. Am J Respir Crit Care Med. 2019 Sep 15;200(6):751-759. doi: 10.1164/rccm.201812-2348OC. Am J Respir Crit Care Med. 2019. PMID: 30995069 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results